Antibody-Drug Conjugates (ADCs) are targeted cancer therapies that combine an antibody specific to cancer cells with a cytotoxic drug. This allows for direct delivery of the drug to the cancer cells, minimizing damage to healthy cells.
Antibody-Drug Conjugates (ADCs) are targeted cancer therapies that combine an antibody specific to cancer cells with a cytotoxic drug. This allows for direct delivery of the drug to the cancer cells, minimizing damage to healthy cells.
© 2024 TFS HealthScience | Contract Research Organization | Global Resourcing Provider | CRO. All rights reserved.
Raise a ConcernPrivacy Policy and CookiesTerms and Conditions